Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.
2.

KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.

Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, Wilkins RJ, Ellory JC, Shen MR.

Cancer Res. 2007 Nov 15;67(22):11064-73.

3.

Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.

Guarino M, Giordano F, Pallotti F, Polizzotti G, Tricomi P, Cristofori E.

Tumori. 1998 May-Jun;84(3):391-7. Review.

PMID:
9678624
4.

Epithelial-to-mesenchymal transition and stem cells in endometrial cancer.

Mirantes C, Espinosa I, Ferrer I, Dolcet X, Prat J, Matias-Guiu X.

Hum Pathol. 2013 Oct;44(10):1973-81. doi: 10.1016/j.humpath.2013.04.009. Epub 2013 Jul 8. Review.

PMID:
23845467
5.

Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.

de Jong RA, Nijman HW, Wijbrandi TF, Reyners AK, Boezen HM, Hollema H.

Mod Pathol. 2011 Oct;24(10):1368-79. doi: 10.1038/modpathol.2011.88. Epub 2011 May 13.

6.

Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin.

Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T.

Cells Tissues Organs. 2005;179(1-2):56-65. Review.

PMID:
15942193
7.

Impairment of the ubiquitin-proteasome system by cellular FLIP.

Ishioka T, Katayama R, Kikuchi R, Nishimoto M, Takada S, Takada R, Matsuzawa S, Reed JC, Tsuruo T, Naito M.

Genes Cells. 2007 Jun;12(6):735-44.

8.

Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition.

Perez-Pinera P, Alcantara S, Dimitrov T, Vega JA, Deuel TF.

Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17795-800. Epub 2006 Nov 10.

9.

The ubiquitin-proteasome system is inhibited by p53 protein expression in human ovarian cancer cells.

Hwang IY, Baguley BC, Ching LM, Gilchrist CA.

Cancer Lett. 2010 Aug 1;294(1):82-90. doi: 10.1016/j.canlet.2010.01.025. Epub 2010 Feb 13.

PMID:
20153923
10.

Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours.

Abeln EC, Smit VT, Wessels JW, de Leeuw WJ, Cornelisse CJ, Fleuren GJ.

J Pathol. 1997 Dec;183(4):424-31.

PMID:
9496259
11.

TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.

Räsänen K, Vaheri A.

J Dermatol Sci. 2010 May;58(2):97-104. doi: 10.1016/j.jdermsci.2010.03.002. Epub 2010 Mar 17.

PMID:
20399617
12.

Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.

Mikami Y, Hata S, Kiyokawa T, Manabe T.

Mod Pathol. 2002 Sep;15(9):923-30.

13.

Pathology of mixed Müllerian tumours.

D'Angelo E, Prat J.

Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):705-18. doi: 10.1016/j.bpobgyn.2011.05.010. Epub 2011 Jul 13. Review.

PMID:
21742560
14.

Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.

Voutsadakis IA.

Tumour Biol. 2012 Aug;33(4):897-910. doi: 10.1007/s13277-012-0355-x. Epub 2012 Mar 6. Review.

PMID:
22399444
15.

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J.

Cancer Res. 2008 Feb 15;68(4):989-97. doi: 10.1158/0008-5472.CAN-07-2017.

16.

Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.

Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y.

Cancer Res. 2008 Jul 1;68(13):5104-12. doi: 10.1158/0008-5472.CAN-07-5680.

17.

β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.

Lacroix-Triki M, Geyer FC, Lambros MB, Savage K, Ellis IO, Lee AH, Reis-Filho JS.

Mod Pathol. 2010 Nov;23(11):1438-48. doi: 10.1038/modpathol.2010.141. Epub 2010 Aug 6.

18.

Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.

Paul S.

Bioessays. 2008 Nov;30(11-12):1172-84. doi: 10.1002/bies.20852. Review.

PMID:
18937370
19.

Regulation of the stability of cell surface E-cadherin by the proteasome.

Saitoh M, Shirakihara T, Miyazono K.

Biochem Biophys Res Commun. 2009 Apr 17;381(4):560-5. doi: 10.1016/j.bbrc.2009.02.098. Epub 2009 Feb 24.

PMID:
19245796
20.

Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.

Kernochan LE, Garcia RL.

J Natl Compr Canc Netw. 2009 May;7(5):550-6; quiz 557. Review.

PMID:
19460280

Supplemental Content

Support Center